The first double-blind randomized placebo-controlled phase 2 study to assess the efficacy and safety of insulin sensitizer in patients with non-alcoholic steatohepatitis in Asia- an interim report

被引：0

作者：

Yeh, Ming-Lun ^{[1
,2
]}

Huang, Chung-Feng ^{[1
,2
,3
]}

Tsai, Pei-Chien ^{[2
]}

Huang, Ching-I ^{[1
,2
,3
]}

Dai, Chia-Yen ^{[1
,2
,3
]}

Chen, Shinn-Chern ^{[1
,2
]}

Huang, Jee-Fu ^{[1
,2
,3
,4
,5
]}

Yu, Ming-Lung ^{[1
,2
,4
,5
]}

Chuang, Wan-Long ^{[1
,2
]}

机构：

[1] Kaohsiung Med Univ, Fac Internal Med, Coll Med, Kaohsiung, Taiwan

[2] Kaohsiung Med Univ Hosp, Hepatobiliary Div, Dept Internal Med, Kaohsiung, Taiwan

[3] Kaohsiung Med Univ Hosp, Grad Inst Clin Med, Kaohsiung, Taiwan

[4] Kaohsiung Med Univ Hosp, Ctr Liquid Biopsy, Kaohsiung, Taiwan

[5] Kaohsiung Med Univ Hosp, Canc Res Ctr, Kaohsiung, Taiwan

来源：

JOURNAL OF HEPATOLOGY | 2020年 / 73卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

FRI101

引用

页码：S449 / S449

页数：1

共 50 条

[1] Insulin sensitizer MSDC-0602K in non-alcoholic steatohepatitis: A randomized, double-blind, placebo-controlled phase IIb study
Harrison, Stephen A.
Alkhouri, Naim
Davison, Beth A.
Sanyal, Arun
Edwards, Christopher
Colca, Jerry R.
Lee, Bo Hyun
Loomba, Rohit
Cusi, Kenneth
Kolterman, Orville
Cotter, Gad
Dittrich, Howard C.
JOURNAL OF HEPATOLOGY, 2020, 72 (04) : 613 - 626
[2] Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study
Armstrong, Matthew James
Gaunt, Piers
Aithal, Guruprasad P.
Barton, Darren
Hull, Diana
Parker, Richard
Hazlehurst, Jonathan M.
Guo, Kathy
Abouda, George
Aldersley, Mark A.
Stocken, Deborah
Gough, Stephen C.
Tomlinson, Jeremy W.
Brown, Rachel M.
Huebscher, Stefan G.
Newsome, Philip N.
LANCET, 2016, 387 (10019): : 679 - 690
[3] SILYMARIN FOR THE TREATMENT OF NON-ALCOHOLIC STEATOHEPATITIS: INTERIM ANALYSIS OF A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
Chan, W. K.
Mustapha, N. R. Nik
Mahadeva, S.
JOURNAL OF HEPATOLOGY, 2015, 62 : S269 - S269
[4] Silymarin for the treatment of non-alcoholic steatohepatitis: Interim analysis of a randomized, double-blind, placebo-controlled trial
Chan, Wah-Kheong
Mustapha, Nik Raihan Nik
Mahadeva, Sanjiv
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2015, 30 : 324 - 325
[5] Efruxifermin in non-alcoholic steatohepatitis: a randomized, double-blind, placebo-controlled, phase 2a trial
Stephen A. Harrison
Peter J. Ruane
Bradley L. Freilich
Guy Neff
Rashmee Patil
Cynthia A. Behling
Chen Hu
Erica Fong
Brittany de Temple
Erik J. Tillman
Timothy P. Rolph
Andrew Cheng
Kitty Yale
Nature Medicine, 2021, 27 : 1262 - 1271
[6] Efruxifermin in non-alcoholic steatohepatitis: a randomized, double-blind, placebo-controlled, phase 2a trial
Harrison, Stephen A.
Ruane, Peter J.
Freilich, Bradley L.
Neff, Guy
Patil, Rashmee
Behling, Cynthia A.
Hu, Chen
Fong, Erica
de Temple, Brittany
Tillman, Erik J.
Rolph, Timothy P.
Cheng, Andrew
Yale, Kitty
NATURE MEDICINE, 2021, 27 (07) : 1262 - +
[7] Probucol in the treatment of non-alcoholic steatohepatitis: A placebo-controlled double-blind study
Malekzadeh, R
Merat, S
Sotoudeh, M
Sohrabi, MR
Naseri-Moghadam, S
Mikaeli, J
Farahvash, MJ
Sotoudahmanesh, R
Ansari, R
Khatibian, M
GASTROENTEROLOGY, 2002, 122 (04) : A24 - A24
[8] First-in-Asian double-blind randomized trial to assess the efficacy and safety of insulin sensitizer in nonalcoholic steatohepatitis patients
Huang, Jee-Fu
Dai, Chia-Yen
Huang, Chung-Feng
Tsai, Pei-Chien
Yeh, Ming-Lun
Hsu, Po-Yau
Huang, Shiu-Feng
Bair, Ming-Jong
Hou, Nai-Jen
Huang, Ching-, I
Liang, Po-Cheng
Lin, Yi-Hung
Wang, Chih-Wen
Hsieh, Ming-Yen
Chen, Shinn-Chern
Lin, Zu-Yau
Yu, Ming-Lung
Chuang, Wan-Long
HEPATOLOGY INTERNATIONAL, 2021, 15 (05) : 1136 - 1147
[9] First-in-Asian double-blind randomized trial to assess the efficacy and safety of insulin sensitizer in nonalcoholic steatohepatitis patients
Jee-Fu Huang
Chia-Yen Dai
Chung-Feng Huang
Pei-Chien Tsai
Ming-Lun Yeh
Po-Yau Hsu
Shiu-Feng Huang
Ming-Jong Bair
Nai-Jen Hou
Ching-I Huang
Po-Cheng Liang
Yi-Hung Lin
Chih-Wen Wang
Ming-Yen Hsieh
Shinn-Chern Chen
Zu-Yau Lin
Ming-Lung Yu
Wan-Long Chuang
Hepatology International, 2021, 15 : 1136 - 1147
[10] A PHASE 2a, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFICACY, AND SAFETY OF ALS-L1023 IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE
Yoon, Eileen
Park, Huiyul
Ahn, Sang Bong
Oh, Hyunwoo
Lee, Hyo Young
Sohn, Joo Hyun
Jun, Dae Won
HEPATOLOGY, 2023, 78 : S1185 - S1186

← 1 2 3 4 5 →